Labiotech.eu

News and Trends 19 Sep 2022

Kamari Pharma raises $8M in investment for development of drugs for skin diseases

An $8 million investment has been raised by Kamari Pharma following investment from the Guangzhou-Israel Biotechnology Fund (GIBF) that creates added value for Israeli, European and American companies looking to expand in China. Kamari Pharma was established at the end of 2018 by the leading Israeli based biotechnology funds Pontifax and Arkin Bioholdings. Prior to […]

September 19, 2022 - 3 minutesmins - By Liza Laws

News and Trends 19 Sep 2022

Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy

The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a global consortium aiming to apply RNA-based therapeutics to successfully unlock anti-cancer immune responses. While RNA-based therapies, namely mRNA vaccines, shone during the pandemic and saved millions of lives, they have yet to be successfully tested […]

September 19, 2022 - 2 minutesmins - By Jim Cornall

circulating tumor cells, cancer, clinical trials

News and Trends 19 Sep 2022

Tokyo scientists reveal possible new direction for getting rid of cancer cells

Scientists from Tokyo University of Science have revealed how autophagy regulates the elimination of transformed cells that can initiate cancer. The elimination is necessary to maintain tissue integrity. The scientists have found that intact autograph vacuoles are indispensable in mediating competitive elimination of the cancer cells. They also noted perturbation of autophagy prevents cell […]

September 19, 2022 - 4 minutesmins - By Liza Laws

News and Trends 19 Sep 2022

Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing

Anyong Biotechnology is the first company in its region to use the most advanced freezing technology in Asia, it was announced today (September 19). The aquatic food processing company based in Taiwan has employed Cells Alive System (CAS) technology from Japan. Originally a medical-grade technology for freezing stem cells, Anyong says CAS is highly praised […]

September 19, 2022 - 3 minutesmins - By Liza Laws

News and Trends 19 Sep 2022

GENFIT to acquire Versantis to expand liver disease portfolio

GENFIT has entered into an exclusivity agreement with a view to acquire all the share capital and voting rights of Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases. GENFIT said the acquisition fits its strategic vision of becoming a global leader in ACLF (acute-on-chronic […]

September 19, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 19 Sep 2022

Biologics manufacturing facility launched by Evotec SE in Toulouse

Construction of a biologics manufacturing facility commenced on Friday (September 16). It is being built by Evotec at its Campus Curie in Toulouse, is the second facility of its kind, and the first in Europe. It will use Just – Evotec Biologics’ flexible J.POD technology to deliver clinical and commercial manufacturing capacity for biologics. Therapeutic […]

September 19, 2022 - 2 minutesmins - By Liza Laws

News and Trends 19 Sep 2022

Cyxone receives approval for phase 2b rheumatoid arthritis study

Swedish biotech company Cyxone has received approval from the Medical Product Agency (Office for Registration of Medicinal Products, Medical devices and Biocides) and the Central Ethics Committee in Poland to start a clinical phase 2b study with its drug candidate Rabeximod, which is being developed as a treatment for rheumatoid arthritis (RA). “The approval is […]

September 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Sep 2022

FDA approves Heron Therapeutics’ post-op nausea and vomiting drug

Heron Therapeutics, Inc. says the U.S. Food and Drug Administration (FDA) has approved APONVIE (aprepitant) injectable emulsion, for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults. Heron Therapeutics’ APONVIE is the first and only IV formulation of aprepitant for PONV prevention. Administered via a single 30-second IV injection, APONVIE reaches […]

September 19, 2022 - 3 minutesmins - By Jim Cornall

Ilya Pharma enrols first patient in diabetic foot ulcer study

News and Trends 19 Sep 2022

CellResearch Corporation announces positive results of phase I diabetic foot ulcer study

CellResearch Corporation, a Singapore-based biopharma company says it has successfully closed the first phase I study for CorLiCyte, a stem cell therapy derived from umbilical cord lining stem cells, with research partners at the University of Colorado, Anschutz Medical Campus and ClinImmune Cell and Gene Therapy. CorLiCyte is in development for the treatment of serious […]

September 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Sep 2022

FDA boosts Antengene pancreatic cancer treatment

Biopharma company Antengene Corporation Limited says ATG-101, the company’s in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. The company said the ODD will help Antengene facilitate regulatory communication with the FDA, accelerate the clinical development […]

September 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Sep 2022

Bugworks Research and Cytecare Cancer Hospitals to set up cancer research center

Bugworks Research Inc., a clinical stage biopharmaceutical company, and Cytecare Cancer Hospitals are set to collaborate by setting up a dedicated research center. Suresh Ramu, co-founder & CEO, Cytecare Cancer Hospitals, said: “We are excited to partner with Bugworks Research, in this inspiring endeavor to discover novel treatments for different types of cancers. In 2016, […]

September 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 16 Sep 2022

Marengo advancing its lead TCR activator into clinic after FDA clearance

Marengo Therapeutics is advancing its lead TCR activator, STAR0602, into clinic following clearance of its investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA). STAR0602 is a bi-functional fusion antibody that deploys a mechanism of T cell activation that has demonstrated potent single agent activity in PD-1 refractory settings in preclinical […]

September 16, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Kamari Pharma raises $8M in investment for development of drugs for skin diseases

Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy

Tokyo scientists reveal possible new direction for getting rid of cancer cells

Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing

GENFIT to acquire Versantis to expand liver disease portfolio

Biologics manufacturing facility launched by Evotec SE in Toulouse

Cyxone receives approval for phase 2b rheumatoid arthritis study

FDA approves Heron Therapeutics’ post-op nausea and vomiting drug

CellResearch Corporation announces positive results of phase I diabetic foot ulcer study

FDA boosts Antengene pancreatic cancer treatment

Bugworks Research and Cytecare Cancer Hospitals to set up cancer research center

Marengo advancing its lead TCR activator into clinic after FDA clearance

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!